pill version of glp 1 Novo Nordisk launches Wegovy weight-loss in US, triggering price war | Pharmaceuticals industry Comparing Ozempic, Wegovy and Other

The most helpful feedback is always the practical stuff: where it felt best, where it irritated, and whether it stayed on through a normal day

While these remarks largely summarize actions FDA has already taken, they highlight compounded GLP-1 products as an area of concern, and this area is likely to be one of continued FDA interest in 2026

Please keep in mind, if you refill your current medication on or after 7/1/2025, youll need to pay the full cost. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark, along with a few other medications that are generally less effective

Because obesity can increase cardiovascular risk, its possible that these benefits are just what you might expect from losing weight

L.SoerjomataramI.et al (2024)